Financial reports
NT 10-K
Notice of late annual filing
1 Apr 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
6 May 22
10-K
2021 FY
Annual report
30 Mar 22
10-Q
2021 Q3
Quarterly report
8 Nov 21
Current reports
8-K
Departure of Directors or Certain Officers
29 Mar 24
8-K
Entry into a Material Definitive Agreement
14 Mar 24
8-K
Entry into a Material Definitive Agreement
9 Jan 24
8-K
Departure of Directors or Certain Officers
28 Dec 23
8-K
Entry into a Material Definitive Agreement
15 Dec 23
8-K
Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update
13 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
16 Oct 23
8-K
Entry into a Material Definitive Agreement
20 Sep 23
8-K
Other Events
18 Sep 23
8-K
Departure of Directors or Certain Officers
15 Sep 23
Registration and prospectus
25-NSE
Exchange delisting
21 Mar 24
S-3
Shelf registration
24 Jan 24
S-8
Registration of securities for employees
24 Jan 24
424B5
Prospectus supplement for primary offering
20 Sep 23
424B5
Prospectus supplement for primary offering
11 Aug 23
424B5
Prospectus supplement for primary offering
24 May 23
S-8
Registration of securities for employees
31 Mar 23
424B5
Prospectus supplement for primary offering
6 May 22
424B5
Prospectus supplement for primary offering
30 Sep 21
S-3
Shelf registration
20 Aug 21
Proxies
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEF 14A
Definitive proxy
31 Oct 22
PRE 14A
Preliminary proxy
17 Oct 22
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
1 Apr 21
DEF 14A
Definitive proxy
1 Apr 21
DEFA14A
Additional proxy soliciting materials
1 Apr 20
DEF 14A
Definitive proxy
1 Apr 20
Other
CT ORDER
Confidential treatment order
24 Apr 23
EFFECT
Notice of effectiveness
31 Aug 21
UPLOAD
Letter from SEC
26 Aug 21
CORRESP
Correspondence with SEC
26 Aug 21
EFFECT
Notice of effectiveness
27 Nov 18
CORRESP
Correspondence with SEC
21 Nov 18
UPLOAD
Letter from SEC
20 Nov 18
CERT
Certification of approval for exchange listing
25 Apr 18
EFFECT
Notice of effectiveness
20 Apr 18
CORRESP
Correspondence with SEC
20 Apr 18